Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDGEBATS:NOVPBATS:OCTDBATS:TSOC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDGEEdge Therapeutics$37.94-0.3%$4.11$0.28▼$17.38$1.20B3.65373,201 shs100 shsNOVPPGIM S&P 500 Buffer 12 ETF - November$27.64+1.2%$26.56$24.64▼$27.96$5.25MN/A679 shsN/AOCTDInnovator Premium Income 10 Barrier ETF - October$23.94+2.2%$23.25$21.41▼$24.67$5.30M0.241,456 shs5,659 shsTSOCInnovator Triple Stacker ETF – October$30.91$30.91$0.00▼$0.00$6.18M0.8N/AN/AA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDGEEdge Therapeutics+1.87%-0.16%+4.21%-4.15%+1,135.96%NOVPPGIM S&P 500 Buffer 12 ETF - November+1.30%-0.14%+4.69%+1.21%+10.63%OCTDInnovator Premium Income 10 Barrier ETF - October+0.16%+0.50%+3.59%-0.42%-2.18%TSOCInnovator Triple Stacker ETF – October0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDGEEdge TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AN/AN/AN/AN/AN/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/AN/AN/AN/AN/AN/AN/AN/ATSOCInnovator Triple Stacker ETF – OctoberN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDGEEdge Therapeutics 0.00N/AN/AN/ANOVPPGIM S&P 500 Buffer 12 ETF - November 0.00N/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - October 0.00N/AN/AN/ATSOCInnovator Triple Stacker ETF – October 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDGEEdge TherapeuticsN/AN/AN/AN/A$0.95 per shareN/ANOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AN/AN/AN/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/AN/AN/AN/AN/AN/ATSOCInnovator Triple Stacker ETF – OctoberN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDGEEdge Therapeutics-$40.86MN/A0.00∞N/AN/A-81.29%-56.92%N/ANOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AN/A0.00∞N/AN/AN/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/AN/A25.02∞N/AN/AN/AN/AN/ATSOCInnovator Triple Stacker ETF – OctoberN/AN/A19.63∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDGEEdge TherapeuticsN/AN/AN/AN/AN/ANOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AN/AN/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - October$1.998.31%N/AN/AN/ATSOCInnovator Triple Stacker ETF – OctoberN/AN/AN/AN/AN/ALatest OCTD, TSOC, EDGE, and NOVP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2025OCTDInnovator Premium Income 10 Barrier ETF - October$0.44733/31/20253/31/20254/1/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDGEEdge TherapeuticsN/A5.595.59NOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AN/AN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/AN/AN/ATSOCInnovator Triple Stacker ETF – OctoberN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDGEEdge Therapeutics28.04%NOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/ATSOCInnovator Triple Stacker ETF – OctoberN/AInsider OwnershipCompanyInsider OwnershipEDGEEdge Therapeutics37.10%NOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/ATSOCInnovator Triple Stacker ETF – OctoberN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDGEEdge TherapeuticsN/A31.51 millionN/ANot OptionableNOVPPGIM S&P 500 Buffer 12 ETF - NovemberN/A190,001N/AN/AOCTDInnovator Premium Income 10 Barrier ETF - OctoberN/A225,000N/ANot OptionableTSOCInnovator Triple Stacker ETF – OctoberN/A200,000N/ANot OptionableOCTD, TSOC, EDGE, and NOVP HeadlinesRecent News About These CompaniesInnovator Premium Income 30 Barrier Etf April Share Chat (APRJ.US)October 8, 2024 | lse.co.ukInnovator Emerging Markets Power Buffer ETF™ - October (EOCT)September 24, 2024 | investing.comInnovator Premium Income 30 Barrier Etf October Share ChatAugust 30, 2024 | lse.co.ukInnovator International Developed 10 Buffer ETF - Quarterly (IBUF)July 19, 2024 | finance.yahoo.comInnovator U.S. Equity Ultra Buffer ETF - July (BATS:UJUL) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comTriple-X ETFs Are Just What Consumers Want, Money Managers Tell SECMay 24, 2023 | thestreet.comInnovator Triple Stacker ETF – October (TSOC)March 5, 2023 | finance.yahoo.comTop HeadlinesView All HeadlinesTop 5 Stocks Hedge Funds Are Buying Right NowBy Ryan Hasson | May 20, 2025View Top 5 Stocks Hedge Funds Are Buying Right NowWhat Ray Dalio's Latest Moves Tell Investors By Gabriel Osorio-Mazilli | May 19, 2025View What Ray Dalio's Latest Moves Tell Investors Renaissance Hedge Fund’s Biggest Q1 Buys RevealedBy Leo Miller | May 22, 2025View Renaissance Hedge Fund’s Biggest Q1 Buys RevealedThe Top 3 Stock Picks at the World’s Greatest Hedge FundBy Leo Miller | May 2, 2025View The Top 3 Stock Picks at the World’s Greatest Hedge FundDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtBy Thomas Hughes | May 29, 2025View Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtOCTD, TSOC, EDGE, and NOVP Company DescriptionsEdge Therapeutics NASDAQ:EDGEPDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.PGIM S&P 500 Buffer 12 ETF - November BATS:NOVP$27.64 +0.33 (+1.22%) As of 01:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The PGIM S&P 500 Buffer 12 ETF - November (NOVP) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPDR S&P 500 ETF Trust over a specific holdings period. The actively managed fund holds options and collateral. NOVP was launched on May 21, 2024 and is issued by PGIM.Innovator Premium Income 10 Barrier ETF - October BATS:OCTD$23.94 +0.52 (+2.24%) As of 12:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Innovator Premium Income 10 Barrier ETF - October (OCTD) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide a consistent income stream and a limited protective barrier against losses over a one-year period. The actively managed fund holds a package of S&P 500 FLEX options and US Treasurys. OCTD was launched on Sep 30, 2023 and is issued by Innovator.Innovator Triple Stacker ETF – October BATS:TSOC$30.91 0.00 (0.00%) As of 10/2/2023The Innovator Triple Stacker ETF – October (TSOC) is an exchange-traded fund that mostly invests in total market equity. The fund aims for cumulative capped gains on SPY, QQQ and IWM shares over a specific holding period. The actively-managed fund holds options and collateral. TSOC was launched on Oct 1, 2020 and is managed by Innovator. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
